Huawang Technology: Zhang Yancheng, the director, plans to reduce the company's shares by no more than 0.3443%. Huawang Technology announced that Zhang Yancheng, the company's director and senior manager, plans to reduce the company's shares by no more than 1.6 million shares through centralized bidding on the Shanghai Stock Exchange within three months after the announcement date, accounting for 0.3443% of the company's total share capital. The reduction price will be determined according to the market price. Zhang Yancheng currently holds 6,671,700 shares of the company, accounting for 1.4357% of the company's total share capital.Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt (full text) and Joint Statement by the Foreign Ministers of People's Republic of China (PRC) and the Arab Republic of Egypt 1. On December 13, 2024, Commissioner the Political Bureau of the Communist Party of China (CPC) Central Committee and Foreign Minister Wang Yi held a strategic dialogue with Egyptian Minister of Foreign Affairs and Immigration Abdul Atti. 2. The two sides exchanged in-depth and comprehensive views on China-Egypt relations and international and regional issues of common concern, and jointly reviewed the development achievements made by the two countries since the establishment of diplomatic relations, especially since the establishment of a comprehensive strategic partnership 10 years ago. 3. The two sides stressed the need to implement the important consensus reached by the two heads of state at their two meetings in 2024, take the "China-Egypt Year of Partnership" as a new starting point, and push bilateral relations to a higher goal of building a community of destiny between China and Egypt facing the new era. The two sides appreciated the many diplomatic, economic, trade, investment, cultural and tourism activities held by the two countries this year to promote and develop bilateral relations in various fields. (Xinhua News Agency)The Bank of Italy said that the economy may only grow by 0.5% this year, and the Bank of Italy said in a statement on Friday that the gross domestic product (GDP) will increase by 0.5% in 2024. If seasonal and calendar effects are not taken into account, this figure will increase to 0.7%, but it is lower than the government's estimate of 1% in the budget. In addition, GDP growth is expected to be 0.8% in 2025 and 1.1% in 2026. It is estimated that the unified average inflation rate in the EU will be 1.1% in 2024, which is the same as the estimated value in October, 1.5% in 2025 and 1.6% in 2025.
Bei Ya raised the Amazon target price from $220.00 to $260.00.General Administration of Financial Supervision: Help boost consumer support and expand bulk consumption, service consumption and new consumption. The Party Committee of the State Financial Supervision and Administration held a meeting to convey the spirit of studying the Central Economic Work Conference. The meeting requested that the real economy should be better served to help boost consumption and support the expansion of bulk consumption, service consumption and new consumption. Strengthen the financing guarantee for investment and effectively serve the "double" and "two new". Expand the pilot of equity investment of financial asset investment companies in an orderly manner. Do a solid job in supporting the financing coordination mechanism of small and micro enterprises. Increase financial support for foreign trade enterprises and strengthen export credit insurance and credit services. Actively guide banks and insurance institutions to reduce costs and increase efficiency, broaden capital replenishment channels, and improve their sustainable development capabilities. Promote high-level financial openness with higher standards and greater efforts, and attract more foreign financial institutions and long-term capital to set up businesses in China.Xinxiangwei: Shareholder Xinyu Yijiade intends to reduce its shareholding by no more than 1%. Xinxiangwei announced that as of the disclosure date, Shareholder Xinyu Yijiade holds 20,175,800 shares of the company, accounting for 4.39% of the company's total share capital. Xinyu Yijiade plans to reduce the number of shares of the company by no more than 4,595,300 shares through centralized bidding or block trading of Shanghai Stock Exchange within 90 days after 15 trading days from the date of announcement, and the proportion of reduced shares in the company's total share capital is no more than 1%.
Ma Zhaoxu, Vice Minister of Foreign Affairs met with New Zealand Ambassador to China Maury, and Ma Zhaoxu, Vice Minister of Foreign Affairs met with outgoing New Zealand Ambassador to China Maury. Ma Zhaoxu said that under the strategic guidance of the leaders of the two countries, China-Singapore relations have maintained sound development, and mutual benefit and win-win have become the main tone of bilateral relations. The two sides should jointly implement the important consensus of the leaders of the two countries and promote the continued healthy and stable development of China-Singapore comprehensive strategic partnership. Mao Rui said that New Zealand is willing to strengthen dialogue and communication with China and push forward bilateral relations. (Ministry of Foreign Affairs)France's new Prime Minister Bayrou: I know my task is arduous, and we need to unite the people. Everyone knows that this road will be long.Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.
Strategy guide
12-14
Strategy guide